Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Haddad

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Psychopharmacology (Oxford, England)|September 17, 2005
Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?P M Haddad, B R Pal, P Clarke, et al.
Journal of Psychiatric and Mental Health Nursing|October 11, 2008
Psychiatric nurses' attitudes to antipsychotic depots in Hong Kong and comparison with LondonM X Patel, F K K Yeung, P M Haddad, et al.
Lancet (London, England)|June 6, 2002
Effects of MDMA (ecstasy) use and abstention on serotonin neuronsP M Haddad, P Strickland, I Anderson, et al.
Journal of Psychopharmacology (Oxford, England)|May 30, 2009
Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 yearsM X Patel, P M Haddad, I B Chaudhry, et al.
Journal De Radiologie, D'Electrologie, Et De Medecine Nucleaire|June 1, 1976
[Radiological exploration of pulmonary systemic hypervascularization. Study of our results concerning 83 cases. Confrontation of the angiographic results with the existence of hemoptysis (author's transl)]C H Hélénon, C Michel, P Jacri, et al.
Acta Psychiatrica Scandinavica|December 18, 2012
A naturalistic evaluation and audit database of agomelatine: clinical outcome at 12 weeksA Sparshatt, R H McAllister Williams, D S Baldwin, et al.
International Journal of Clinical Practice|April 28, 2005
Aripiprazole in schizophrenia: consensus guidelinesM J Travis, T Burns, S Dursun, et al.
Journal of Psychopharmacology (Oxford, England)|November 18, 2008
A UK consensus on the administration of aripiprazole for the treatment of maniaK J Aitchison, M Bienroth, J Cookson, et al.
The British Journal of Nutrition|May 3, 2026
Optimising Nutritional Psychiatry Treatment: Investigating the Mediterranean Diet to Improve Symptoms of Major Depressive Disorder (OPTIMISM): A double-blind sham-controlled randomised feeding trial protocolD S Y Tien, M Hockey, K Muller, et al.
Journal of Psychopharmacology (Oxford, England)|May 6, 2016
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatmentStephen J Cooper, Gavin P Reynolds, , et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Psychopharmacology (Oxford, England)|September 17, 2005
Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?P M Haddad, B R Pal, P Clarke, et al.
Journal of Psychiatric and Mental Health Nursing|October 11, 2008
Psychiatric nurses' attitudes to antipsychotic depots in Hong Kong and comparison with LondonM X Patel, F K K Yeung, P M Haddad, et al.
Lancet (London, England)|June 6, 2002
Effects of MDMA (ecstasy) use and abstention on serotonin neuronsP M Haddad, P Strickland, I Anderson, et al.
Journal of Psychopharmacology (Oxford, England)|May 30, 2009
Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 yearsM X Patel, P M Haddad, I B Chaudhry, et al.
Journal De Radiologie, D'Electrologie, Et De Medecine Nucleaire|June 1, 1976
[Radiological exploration of pulmonary systemic hypervascularization. Study of our results concerning 83 cases. Confrontation of the angiographic results with the existence of hemoptysis (author's transl)]C H Hélénon, C Michel, P Jacri, et al.
Acta Psychiatrica Scandinavica|December 18, 2012
A naturalistic evaluation and audit database of agomelatine: clinical outcome at 12 weeksA Sparshatt, R H McAllister Williams, D S Baldwin, et al.
International Journal of Clinical Practice|April 28, 2005
Aripiprazole in schizophrenia: consensus guidelinesM J Travis, T Burns, S Dursun, et al.
Journal of Psychopharmacology (Oxford, England)|November 18, 2008
A UK consensus on the administration of aripiprazole for the treatment of maniaK J Aitchison, M Bienroth, J Cookson, et al.
The British Journal of Nutrition|May 3, 2026
Optimising Nutritional Psychiatry Treatment: Investigating the Mediterranean Diet to Improve Symptoms of Major Depressive Disorder (OPTIMISM): A double-blind sham-controlled randomised feeding trial protocolD S Y Tien, M Hockey, K Muller, et al.
Journal of Psychopharmacology (Oxford, England)|May 6, 2016
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatmentStephen J Cooper, Gavin P Reynolds, , et al.
Pageof 4